Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas-Reference-Cited by-同舟云学术

Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas

Published:2016-08-20 Issue:2 Volume:44 Page:135-142
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Hamada Toshihisa¹,Sugaya Makoto²,Tokura Yoshiki³,Ohtsuka Mikio⁴,Tsuboi Ryoji⁵,Nagatani Tetsuo⁶,Tani Mamori⁷,Setoyama Mitsuru⁸,Matsushita Shigeto⁹,Kawai Kazuhiro⁹^ORCID,Yonekura Kentaro¹⁰,Yoshida Tsuyoshi¹¹,Saida Toshiaki¹²,Iwatsuki Keiji¹

Affiliation:

1. Department of Dermatology; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan

2. Department of Dermatology; Faculty of Medicine; University of Tokyo; Tokyo Japan

3. Department of Dermatology; Hamamatsu University School of Medicine; Shizuoka Japan

4. Department of Dermatology; Fukushima Medical University; Fukushima Japan

5. Department of Dermatology; Tokyo Medical University; Tokyo Japan

6. Department of Dermatology; Tokyo Medical University Hachioji Medical Center; Tokyo Japan

7. Department of Dermatology; Osaka University Graduate School of Medicine; Osaka Japan

8. Department of Dermatology; Faculty of Medicine; University of Miyazaki; Miyazaki Japan

9. Department of Dermatology; Kagoshima University Graduate School of Medical and Dental Sciences; Kagoshima Japan

10. Department of Dermatology; Imamura Bun-in Hospital; Kagoshima Japan

11. Minophagen Pharmaceutical; Tokyo Japan

12. Department of Dermatology; Shinshu University; Nagano Japan

Funder

Minophagen Pharmaceutical

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.13542/fullpdf

Reference31 articles.

1. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases;Bradford;Blood,2009

2. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002;Criscione;Arch Dermatol,2007

3. Cutaneous lymphoma in Japan: a nationwide study of 1733 patients;Hamada;J Dermatol,2014

4. Current therapy of choice for cutaneous lymphomas: complementary to the Japanese Dermatological Association/Japanese Skin Cancer Society guidelines;Iwatsuki;J Dermatol,2014

5. Treatment of cutaneous T-cell lymphoma with retinouds;Zhang;Dermatol Ther,2006

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties;Journal of Medicinal Chemistry;2024-01-18

2. Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency;Journal of Medicinal Chemistry;2023-12-08

3. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023;European Journal of Cancer;2023-12

4. Impact of body mass index on the severity of bexarotene‐associated hypertriglyceridemia: A post hoc analysis of an open‐labeled clinical study of combined bexarotene and phototherapy in Japanese patients with cutaneous T‐cell lymphoma;The Journal of Dermatology;2023-04-11

5. In vitro–in vivo extrapolation of bexarotene metabolism in the presence of chronic kidney disease and acute kidney injury in rat using physiologically based pharmacokinetic modeling and extrapolation to human;Biopharmaceutics & Drug Disposition;2022-11-21